CASP8 and prostate cancer: The insertion of full-length SINE-VNTR-Alu retrotransposons (SVT) into intron 8 of the caspase-8 gene (CASP8) is associated with an increased risk of basal cell carcinoma and breast cancer but reduces the risk of prostate cancer [62].